Finance
Get the app
Stifel initiates Roivant Sciences stock with buy rating, $51 target
BlogZone shows headlines and summaries from public news feeds. The full story is published by Investing.com.
Read the full story at Investing.com →Enjoyed this?
Get more stories like this — and write your own — in the BlogZone app.
